Director
European Patent Attorney
UK Patent Attorney
UK Design Attorney
MSci Physics, Imperial College London
PhD, Photonics, Imperial College London
Postgraduate Certificate in Intellectual Property, Bournemouth University
Thank you
Emma graduated from Imperial College London in 2009 with a master's degree in Physics, before continuing her studies in the field and at Imperial College by undertaking a PhD in the Photonics Group, followed by a year and a half as a Research Assistant. During this time her research focused on the development of high power diode pumped solid state lasers, using both end-pumped and side-pumped geometries, for use in medical and industrial applications in particular.
Emma decided to make the jump from research into the patent profession in 2015 when she joined the Engineering team at Keltie. Since then, she has worked to support a range of small and large clients, spanning sectors and technologies that include automotive, subsea engineering, optics and photonics, and packaging. Emma has experience in both drafting and prosecution of patent applications, as well as in the filing of design rights in Europe and the US in particular. In addition to her time working for clients from the Keltie offices, Emma has also had the opportunity to undertake an in-house secondment where she was involved in both patent prosecution and invention harvesting.
Emma qualified as a UK patent and design attorney in 2021.
02.05.2025
The Effect of the Unified Patent Court (UPC) on Opposition Proceedings at the European Patent Office (EPO)The introduction of the Unified Patent Court (UPC) has brought significant changes to the European patent landscape. This article, written by Nathaniel Taylor (of Keltie's Opposition and Appeals team), takes a closer look at the impact of the UPC on opposition proceedings at the European Patent Office (EPO). The article draws on a full year's worth of opposition data - available as of 1 April 2025 - for European patents granted since the Unitary Patent system began (i.e., European patents granted between 1 June 2023 and 1 June 2024). The analysis explores overall trends, technology-specific patterns, and the strategic motives behind relative opposition rates.
01.04.2025
Protecting Inventions while preserving biodiversityInvesting in biodiversity conservation and research is not just environmentally responsible—it's medically strategic, as each species lost represents the permanent erasure of unique biochemical compounds that could hold the key to treating current and future diseases. Understanding biodiversity also impacts diverse fields such as animal and plant breeding, agritech and public health.
OtherLess related knowledge
Thank you
